Sees FY26 revenue flat to up 1%. Sees FY26 organic sales approximately flat.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Notable companies reporting before tomorrow’s open
- Baxter International: Discounted Valuation and Efficiency Upside Offset by Execution and Product Risk, Justifying Hold
- Is BAX a Buy, Before Earnings?
- Baxter price target lowered to $30 from $36 at Barclays
- Baxter price target raised to $23 from $22 at Goldman Sachs
